Search results
Showing 121 to 135 of 1371 results for patients and public
In development [GID-TA11390] Expected publication date: 24 July 2024
This quality standard covers ways to reduce suicide and help people bereaved or affected by suicide. It describes high-quality care in priority areas for improvement.
View quality statements for QS189Show all sections
Sections for QS189
- Quality statements
- Quality statement 1: Multi-agency suicide prevention partnerships
- Quality statement 2: Reducing access to methods of suicide
- Quality statement 3: Media reporting
- Quality statement 4: Involving family, carers or friends
- Quality statement 5: Supporting people bereaved or affected by a suspected suicide
- Update information
- About this quality standard
This quality standard covers diagnosing and managing common types of headache in adults and young people (aged 12 and over). It includes tension-type headache, migraine, cluster headache and medication overuse headache. It describes high-quality care in priority areas for improvement.
View quality statements for QS42Show all sections
Sections for QS42
- Quality statements
- Quality statement 1: Classification of headache type
- Quality statement 2: Preventing medication overuse headache
- Quality statement 3: Imaging
- Quality statement 4: Combined treatment for migraine
- Quality statement 5 (placeholder): Raising public and professional awareness
- Update information
- About this quality standard
In development [GID-TA11197] Expected publication date: TBC
In development [GID-TA10778] Expected publication date: 11 December 2024
Exagamglogene autotemcel for treating sickle cell disease [ID4016]
In development [GID-TA11249] Expected publication date: 17 July 2024
Fosdenopterin for treating molybdenum cofactor deficiency type A [ID6264]
In development [GID-HST10055] Expected publication date: 29 January 2025
Belzutifan for treating tumours associated with von Hippel-Lindau disease [ID3932]
In development [GID-TA10817] Expected publication date: TBC
In development [GID-TA11263] Expected publication date: TBC
We are listening to your views on this Diagnostics guidance. Comments close 26 April 2024.
This quality standard covers the mental wellbeing of older people (aged 65 and over) receiving care in care homes (including residential and nursing accommodation, day care and respite care). It focuses on support for people to improve their mental wellbeing so that they can stay as well and independent as possible. It describes high-quality care in priority areas for improvement.
View quality statements for QS50Show all sections
Sections for QS50
- Quality statements
- Quality statement 1: Participation in meaningful activity
- Quality statement 2: Personal identity
- Quality statement 3: Recognition of mental health conditions
- Quality statement 4: Recognition of sensory impairment
- Quality statement 5: Recognition of physical problems
- Quality statement 6: Access to healthcare services
- Update information
In development [GID-TA10143] Expected publication date: TBC
In development [GID-TA11184] Expected publication date: TBC
Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A [ID6170]
In development [GID-TA11106] Expected publication date: TBC
Avapritinib for treating advanced systemic mastocytosis ID3770
In development [GID-TA11382] Expected publication date: TBC